# Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia

> **NCT06922669** · NA · RECRUITING · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 232 (estimated)

## Conditions studied

- Drug Induced Liver Injury

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** Magnesium isoglycyrrhizinate
- **DRUG:** Glutathione
- **DRUG:** Silymarin
- **DRUG:** Polyene Phosphatidylcholine
- **DRUG:** Ursodeoxycholic acid capsules
- **DRUG:** Ademetionine 1,4-Butanedisulfonate
- **PROCEDURE:** Plaslna exchange
- **PROCEDURE:** Liver transplantation

## Key facts

- **NCT ID:** NCT06922669
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-24
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922669, "Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06922669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*